Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder

OBJECTIVES: Approximately 40-60% of obsessive-compulsive disorder patients are nonresponsive to serotonin reuptake inhibitors. Genetic markers associated with treatment response remain largely unknown. We aimed (1) to investigate a possible association of serotonergic polymorphisms in obsessive-comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Corregiari, Fábio M, Bernik, Márcio, Cordeiro, Quirino, Vallada, Homero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317252/
https://www.ncbi.nlm.nih.gov/pubmed/22522758
http://dx.doi.org/10.6061/clinics/2012(04)06

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317252/
https://www.ncbi.nlm.nih.gov/pubmed/22522758
http://dx.doi.org/10.6061/clinics/2012(04)06

Ejemplares similares